CoChat

Adenoviral vector-mediated expression of a gene encoding secreted, EpCAM-targeted carboxylesterase-2 sensitises colon cancer spheroids to CPT-11

Open access
Oosterhoff, D, Overmeer, R M, de Graaf, M, van der Meulen, I H, Giaccone, G, van Beusechem, V W, Haisma, H J, Pinedo, H M, Gerritsen, W R · 2005 · British Journal of Cancer

The DOI matches its Crossref record; 22 of the 23 references it cites were found in a registry or an index.

Abstract

CPT-11 (irinotecan or 7-ethyl-10[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin) is an anticancer agent in use for the treatment of colon cancer. In order to be fully active, CPT-11 needs to be converted into SN-38 (7-ethyl-10-hydroxycamptothecin) by the enzyme carboxylesterase (CE). In humans, only a minority of CPT-11 is converted to SN-38. To increase the antitumour effect of CPT-11 by gene-directed enzyme prodrug therapy, we constructed a replication-deficient adenoviral vector Ad.C28-sCE2 containing a fusion gene encoding a secreted form of human liver CE2 targeted to the surface antigen epithelial cell adhesion molecule (EpCAM) that is highly expressed on most colon carcinoma cells. By targeting CE2 to EpCAM, the enzyme should accumulate specifically in tumours and leakage into the circulation should be minimised. Ad.C28-sCE2-transduced colon carcinoma cells expressed and secreted active CE that bound specifically to EpCAM-expressing cells. In sections of three-dimensional colon carcinoma spheroids transduced with Ad.C28-sCE2, it was shown that C28-sCE2 was capable of binding untransduced cells. Most importantly, treatment of these spheroids with nontoxic concentrations of CPT-11 resulted in growth inhibition comparable to treatment with SN-38. Therefore, Ad.C28-sCE2 holds promise in gene therapy approaches for the treatment of colon carcinoma.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjc.6602362

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Schematic structure of the replication-deficient adenovirus Ad.C28-sCE2 and characterisation of Ad.C28-sCE2-transduced SW1398 cells by Western blot analysis, esterase activity assay and immunohistochemistry. (A) Schematic structure of the replication-deficient adenovirus Ad.C28-sCE2. The C28-sCE2 expression cassette includes the CMV promoter, an IgGκ leader sequence for secretion and a C-terminal myc- and His-tag for detection and purification. The adenovirus also contains the gene encoding GFP under the CMV promoter. (B) Western blot analysis of cellular lysates (lanes 1 and 2) and supernatants (lanes 3 and 4) of SW1398 cells transduced with Ad.C28-sCE2 (lanes 1 and 3) or AdGFP (lanes 2 and 4) at an MOI of 100. C28-sCE2 was detected using an antibody directed to the myc-tag. (C) CE activity in cellular lysates and supernatants of SW1398 cells transduced with Ad.C28-sCE2 or AdGFP at an MOI of 100. Cellular lysates or supernatants were incubated with 1 mM pNpAc and conversion was measured during 10 min. C28-sCE2 showed enzymatic activity and was efficiently secreted by transduced cells, since most of the activity was detected in the supernatant. (D) Binding of C28-sCE2 to the EpCAM-expressing cell line Colo205. Colo205 cells or the EpCAM-negative cell line A2780 were incubated with the supernatant of SW1398 cells transduced with Ad.C28-sCE2 or AdGFP at an MOI of 100. After washing, the cells were stained with anti-myc antibody to show binding of C28-sCE2. Only the EpCAM-expressing Colo205 cells incubated with supernatant of Ad.C28-sCE2-transduced SW1398 cells showed a positive membrane staining, indicating that the fusion protein had bound specifically to the Colo205 cells.
Figure 1 Schematic structure of the replication-deficient adenovirus Ad.C28-sCE2 and characterisation of Ad.C28-sCE2-transduced SW1398 cells by Western blot analysis, esterase activity assay and immunohistochemistry. (A) Schematic structure of the replication-deficient adenovirus Ad.C28-sCE2. The C28-sCE2 expression cassette includes the CMV promoter, an IgGκ leader sequence for secretion and a C-terminal myc- and His-tag for detection and purification. The adenovirus also contains the gene encoding GFP under the CMV promoter. (B) Western blot analysis of cellular lysates (lanes 1 and 2) and supernatants (lanes 3 and 4) of SW1398 cells transduced with Ad.C28-sCE2 (lanes 1 and 3) or AdGFP (lanes 2 and 4) at an MOI of 100. C28-sCE2 was detected using an antibody directed to the myc-tag. (C) CE activity in cellular lysates and supernatants of SW1398 cells transduced with Ad.C28-sCE2 or AdGFP at an MOI of 100. Cellular lysates or supernatants were incubated with 1 mM pNpAc and conversion was measured during 10 min. C28-sCE2 showed enzymatic activity and was efficiently secreted by transduced cells, since most of the activity was detected in the supernatant. (D) Binding of C28-sCE2 to the EpCAM-expressing cell line Colo205. Colo205 cells or the EpCAM-negative cell line A2780 were incubated with the supernatant of SW1398 cells transduced with Ad.C28-sCE2 or AdGFP at an MOI of 100. After washing, the cells were stained with anti-myc antibody to show binding of C28-sCE2. Only the EpCAM-expressing Colo205 cells incubated with supernatant of Ad.C28-sCE2-transduced SW1398 cells showed a positive membrane staining, indicating that the fusion protein had bound specifically to the Colo205 cells.CC BY · PubMed Central
Figure 2 Immunohistochemistry on sections of Ad.C28-sCE2-transduced Colo205 spheroids. Colo205 spheroids were transduced with 1 × 107 PFU Ad.C28-sCE2 and harvested at day 1, 4 and 5 after transduction. Sections of these spheroids were made and stained for myc to detect C28-sCE2. (A) At day 1 after Ad.C28-sCE2 transduction, no positive staining can be detected. At days 4 and 5, several spots along the rim of the spheroid are positively stained. (B) A higher magnification of the fusion protein staining at day 5 after transduction is shown. Cells with clear staining of membranes only (arrows) represent untransduced neighbouring cells with bound C28-sCE2.
Figure 2 Immunohistochemistry on sections of Ad.C28-sCE2-transduced Colo205 spheroids. Colo205 spheroids were transduced with 1 × 107 PFU Ad.C28-sCE2 and harvested at day 1, 4 and 5 after transduction. Sections of these spheroids were made and stained for myc to detect C28-sCE2. (A) At day 1 after Ad.C28-sCE2 transduction, no positive staining can be detected. At days 4 and 5, several spots along the rim of the spheroid are positively stained. (B) A higher magnification of the fusion protein staining at day 5 after transduction is shown. Cells with clear staining of membranes only (arrows) represent untransduced neighbouring cells with bound C28-sCE2.CC BY · PubMed Central
Figure 3 Cytotoxicity assay on SW1398 and Colo205 colon cancer spheroids. SW1398 (A) and Colo205 (B) spheroids were transduced with 1 × 107 PFU AdGFP or Ad.C28-sCE2. At 7 days after infection, spheroids were subjected to a range of CPT-11 concentrations and cultured for a further 7 days. Cell viability of untransduced spheroids treated with CPT-11 (closed black circles) or SN-38 (open black circles), AdGFP-transduced spheroids treated with CPT-11 (open black triangles) and Ad.C28-sCE2-transduced spheroids treated with CPT-11 (closed black squares) were analysed by WST-1 conversion measurement.
Figure 3 Cytotoxicity assay on SW1398 and Colo205 colon cancer spheroids. SW1398 (A) and Colo205 (B) spheroids were transduced with 1 × 107 PFU AdGFP or Ad.C28-sCE2. At 7 days after infection, spheroids were subjected to a range of CPT-11 concentrations and cultured for a further 7 days. Cell viability of untransduced spheroids treated with CPT-11 (closed black circles) or SN-38 (open black circles), AdGFP-transduced spheroids treated with CPT-11 (open black triangles) and Ad.C28-sCE2-transduced spheroids treated with CPT-11 (closed black squares) were analysed by WST-1 conversion measurement.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 26

Metadata

Authors
Oosterhoff, D., Overmeer, R. M., de Graaf, M., van der Meulen, I. H., Giaccone, G., van Beusechem, V. W., Haisma, H. J., Pinedo, H. M., & Gerritsen, W. R.
Affiliations
  • Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
  • University of Groningen (NL)
Corresponding author
Oosterhoff, D
Venue
British Journal of Cancer
Published
2005-03
Volume
92
Issue
5
Pages
882-887
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W2140098860
Cited by
26
References
23
Citations by year
2024: 1 · 2023: 2 · 2022: 4 · 2021: 1 · 2019: 1 · 2018: 1 · 2015: 2 · 2013: 4
FWCI
1.62
Type
journal article
Language
en
Open access
Locations
  • British Journal of Cancer (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, cc-by-nc-sa)
  • Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by-nc-sa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Funders
Koninklijke Nederlandse Akademie van Wetenschappen
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
Keywords
CE2, EpCAM, adenoviral vector, gene-directed enzyme prodrug therapy, irinotecan, SN-38, colon cancer, secreted enzymes, targeted gene delivery, replication-defective adenovirus, gene therapy
MeSH terms
Irinotecan, Adenoviridae, Antineoplastic Agents, Phytogenic, Camptothecin, Cell Survival, Colonic Neoplasms, Female, Genetic Vectors, Humans, Ovarian Neoplasms, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Carboxylesterase, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.